Gas phase reactions of the cyclic ethylenehalonium ions (CH2)2X+ (X = Cl, Br) with glycine

Journal of Organic Chemistry

Volumn 61, Issue 7, 1996, Pages 2374-2382

  O'Hair, Richard A J ^a   Freitas, Michael A ^a   Williams, Todd D ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001409549     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo951960k     Document Type: Article

References (69)

1. Gas Phase Ion Chemistry of Biomolecules, 5. Part 4: see ref 3b.
2. Busch, K. L.; Glish, G. L.; McLuckey, S. A. Mass Spectrometry/ Mass Spectrometry. Techniques & Applications of Tandem Mass Spectrometry; VCH: New York, 1988.
3. (a) O'Hair, R. A. J.; Freitas, M. A.; Gronert, S.; Schmidt, J. A. R.; Williams, T. D. J. Org. Chem. 1995, 60, 1990.
4. (b) O'Hair, R. A. J.; Freitas, M. A.; Schmidt, J. A. R.; Hatley, M. E.; Williams, T. D. Eur. Mass Spectrom., in press.
5. (c) O'Hair, R. A. J.; Freitas, M. A.; Gronert, S.; Schmidt, J. A. R.; Williams, T. D. Proceedings of the 43rd ASMS Conference an Mass Spectrometry and Allied Topics, Atlanta, GA, May 21-26, 1995; p 329.
6. Tome, D.; Naulet, N. Int. J. Peptide Protein Res. 1981, 17, 501.
7. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
8. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
9. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
10. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
11. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
12. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
13. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
14. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
15. For some reviews: (a) Preussman, R. In Biochemistry of Chemical Carcinogenisis; Gardner, R. C., Hradec, J., Eds.; Plenum Press: New York, 1989. (b) Ehrenberg, L.; Osterman-Golkar, S. Teratog. Carcinog. Mutagen. 1980, 1, 105. For the original theory of chemical Carcinogenisis: (c) Miller, J. A.; Miller, E. C. Pharmacol. Rev. 1966, 18, 805. (d) Miller, J. A. Cancer Res. 1970, 30, 559. (e) Miller, E. C.; Miller, J. A. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 173; American Chemical Society: Washington, 1976; Chapter 16. For selected reviews on the sites of modification of DNA see: (f) Lawley, P. D. In Chemical Carcinogens; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, 1984; Chapter 7. (g) Osborne, M. R. In ref 5a, Chapter 8. (h) Basu, A. K.; Essigmann, J. M. Mutat. Res. 1990, 233, 189. For a recent review on the mass spectrometric detection of carcinogenic adducts of both DNA and proteins see: (i) Farmer, P. B.; Sweetman, G. M. A. J. Mass Spectrom. 1995, 30, 1369.
16. (a) Peterson, L. A.; Harris, T. M.; Guengerich, F. P. J. Am. Chem. Soc. 1988, 110, 3284.
17. (b) Erve, J. C. L.; Deinzer, M. L.; Reed, D. J. Chem. Res. Toxicol. 1995, 8, 414.
18. (c) Davis, M. R.; Baillie, T. A. J. Mass Spectrom. 1995, 30, 57.
19. (a) Rodriquez, C. F.; Bohme, D. K.; Hopkinson, A. C. J. Am. Chem. Soc. 1993, 115 , 3263.
20. (b) Hamilton, T. P.; Schaefer, H. F. J. Am. Chem. Soc. 1990, 112, 8260.
21. (a) Berman, D. W.; Anicich, V.; Beauchamp, J. L. J. Am. Chem. Soc. 1979, 101, 1239.
22. (b) Heck, A. J. R.; de Koning, L. J.; Nibbering, N. M. M. Org. Moss Spectrom. 1993, 28, 235.
23. (c) Vairamani, M.; Saraswathi, M.; Viswanadha Rao, G. K. Org. Mass Spectrom. 1991, 26, 786.
24. (d) Vairamani, M.; Srinivas, R.; Mirza, U. A. Org. Mass Spectrom. 1988, 23, 620.
25. (a) Miller, A. W.; Stirling, C. J. M. J. Chem. Soc. C 1968, 2612.
26. (b) Kunz, H.; Buchholz, M. Chem. Ber. 1979, 112, 2145.
27. (c) Knapp, D. P. Methods Enzymol. 1990, 193, 314.
28. (a) Jankowski, K.; Berse, C. Can. J. Chem. 1968, 46, 1939.
29. (b) Van der Plas, H. C. Ring Transformations of Heterocycles; Academic Press: London, 1973; Vol. 1, pp 38-39.
30. GAMESS (Sun Microsystems Inc. Version: 24 May 1995, Iowa State University): Schmidt, M. W.; Baldridge, K. K.; Boatz, J. A.; Elbert, S. T.; Gordon, M. S.; Jensen, J. H.; Koseki, S.; Matsunaga, N. Nguyen, K. A.; Su, S. J.; Windus, T. L., Together Dupuis, M.; Montgomery, J. A.
31. (a) Hariharan, P. C.; Pople, J. A. Theor. Chim. Acta 1973, 28, 213.
32. (b) Dill, J. D.; Pople, J. A. J. Chem. Phys. 1975, 62, 2921.
33. (c) Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Gordon, M. S.; DeFrees, D. J.; Pople, J. A. J. Chem. Phys. 1982, 77, 3654.
34. Pople, J. A.; Schlegel, H. B.; Krishnan, R.; DeFrees, D. J.; Binkley, J. S.; Frisch, M. J.; Whiteside, R. A.; Hout, R. F.; Hehre, W. J. Int. J. Quantum Chem. Symp. 1981, 15, 269.
35. Gronert, S.; O'Hair, R. A. J., J. Am. Chem. Soc. 1995, 117, 2071.
36. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. P. P. J. Am. Chem. Soc. 1985, 107, 3902.
37. 2 CI conditions see: (a) Tsang, C. W.; Harrison, A. G. J. Am. Chem. Soc. 1976, 98, 1301. (b) Leclercq, P. A.; Desiderio, D. M. Org. Mass Spectrom. 1973, 7, 515.
38. 2 CI conditions see: (a) Tsang, C. W.; Harrison, A. G. J. Am. Chem. Soc. 1976, 98, 1301. (b) Leclercq, P. A.; Desiderio, D. M. Org. Mass Spectrom. 1973, 7, 515.
39. (a) Bordwell, F. G.; Andersen, H. M.; Pitt, B. M. J. Am. Chem. Soc. 1954, 76, 1082.
40. (b) Gronert, S.; Lee, J. M. J. Org Chem. 1995, 60, 4488.
41. (a) Kotiaho, T.; Shay, B. J.; Cooks, R. G.; Eberlin, M. N. J. Am. Chem. Soc. 1993, 115, 1004.
42. (b) Eberlin, M. N; Kotiaho, T.; Shay, B. J.; Yang, S. S.; Cooks, R. G. J. Am. Chem. Soc. 1994, 116, 2457.
43. 2] from protonated amino acids see: (a) Yalcin, T.; Khouw, C.; Csizmadia, I. G.; Peterson, M. R.; Harrison, A. G. J. Am. Soc. Mass Spectrom. 1995, 6, 1165. (b) Meot-Ner, M.; Field, F. H. J. Am. Chem. Soc. 1973, 95, 7207.
44. 2] from protonated amino acids see: (a) Yalcin, T.; Khouw, C.; Csizmadia, I. G.; Peterson, M. R.; Harrison, A. G. J. Am. Soc. Mass Spectrom. 1995, 6, 1165. (b) Meot-Ner, M.; Field, F. H. J. Am. Chem. Soc. 1973, 95, 7207.
45. Monstrey, J.; Van de Sande, C. C.; Levsen, K.; Heimbach, H.; Borchers, F., J. Chem. Soc., Chem. Commun. 1978, 796.
46. We recognize that these ratios should only be used in a qualitative sense since they are likely to depend on the internal energy content of the source-generated ions (see ref 2).
47. 2H where X = Cl, Br) since there is no reported procedure for their synthesis in the literature.
48. For an excellent review of ion-molecule complexes (sometimes called ion-neutral complexes) in the gas phase (including their role in isomerization reactions) see: Bowen, R. D. Acc. Chem. Res. 1991, 24, 364.
49. (a) March, J. Advanced Organic Chemistry, 4th ed.; Wiley: New York, 1992; pp 308-312.
50. (b) Angelini, G.; Speranza, M. J. Am. Chem. Soc. 1981, 103, 3792.
51. The MS/MS spectra of ions of structures G and J were not studied since there are no literature syntheses of the neutral precursors to G or J.
52. 2Br plasma were studied on two different occasions (separated by about 6 months) and gave reproducible results.
53. Heck, A. J. R.; de Koning, L. J.; Nibbering, N. M. M. Org. Mass Spectrom. 1993, 28, 245
54. + ions.
55. See: Barone, V.; Lelj, F.; Grande, P.; Russo, N.; Toscano, M. Chem. Phys. Lett. 1987, 133, 548 and references therein.
56. Olah, G. A.; Donovan, D. J.; Keefer, L. K. J. Nat. Cancer. Inst. 1975, 54, 465.
57. 2O, has been investigated by both MS/MS experiments and ab initio calculations: (a) Heerma, W.; Kulik, W.; Burgers, P. C.; Terlouw, J. K. Int. J. Mass Spectrom. Ion Proc. 1988, 84, R1. (b) Bouchoux, G., Hoppilliard, Y. Int. J. Mass Spectrom. Ion. Proc. 1987, 75, 1.
58. 2O, has been investigated by both MS/MS experiments and ab initio calculations: (a) Heerma, W.; Kulik, W.; Burgers, P. C.; Terlouw, J. K. Int. J. Mass Spectrom. Ion Proc. 1988, 84, R1. (b) Bouchoux, G., Hoppilliard, Y. Int. J. Mass Spectrom. Ion. Proc. 1987, 75, 1.
59. Cooks, R. G.; Patrick, J. S.; Kotiaho, T.; McLuckey, S. A. Mass Spectrom. Rev. 1994, 13, 287.
60. Peerboom, R. A. L.; Ingemann, S.; Nibbering, N. M. M.; Liebman, J. F. J. Chem. Soc., Perkin Trans. 2 1990, 1825.
61. Lias, S. G.; Bartmess, J. E.; Liebman, J. F.; Holmes, J. L.; Levin, R. D.; Mallard, W. G. J. Phys. Chem. Ref. Data 1988, 17, Suppl. 1.
62. (a) Hayes, R. N.; Grese, R. P.; Gross, M. L. J. Am. Chem. Soc. 1989, 111, 8336.
63. (b) Wood, K. V.; Burinsky, D. J.; Cameron, D.; Cooks, R. G. J. Org. Chem. 1983, 48, 5236.
64. We thank a reviewer for pointing out the following additional examples: (a) Meot-Ner, M.; Ross, M. M.; Campana, J. E. J. Am. Chem. Soc. 1985, 107, 4839. (b) Sunner, J. A.; Hirao, K.; Kebarle, P. J. Phys. Chem. 1989, 93, 4010. (c) Norrman, K.; McMahon, T. B. Proceedings of the 42nd ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, IL, May 29-June 3, 1994, p 544.
65. We thank a reviewer for pointing out the following additional examples: (a) Meot-Ner, M.; Ross, M. M.; Campana, J. E. J. Am. Chem. Soc. 1985, 107, 4839. (b) Sunner, J. A.; Hirao, K.; Kebarle, P. J. Phys. Chem. 1989, 93, 4010. (c) Norrman, K.; McMahon, T. B. Proceedings of the 42nd ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, IL, May 29-June 3, 1994, p 544.
66. We thank a reviewer for pointing out the following additional examples: (a) Meot-Ner, M.; Ross, M. M.; Campana, J. E. J. Am. Chem. Soc. 1985, 107, 4839. (b) Sunner, J. A.; Hirao, K.; Kebarle, P. J. Phys. Chem. 1989, 93, 4010. (c) Norrman, K.; McMahon, T. B. Proceedings of the 42nd ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, IL, May 29-June 3, 1994, p 544.
67. (a) Olah, G. A. Halonium Ions; Wiley: New York, 1975.
68. (b) Koser, G. F. In The Chemistry of Halides, Pseudo-Halides and Azides; Patai, S., Rappoport, Z., Eds.; Wiley: Chichester, 1983: Part 2, p 1265.
69. Antelo, J. M.; Arce, F.; Crugeiras, J. J. Chem. Soc., Perkin Trans. 2 1995, 2275.